About Recursion Pharmaceuticals
Recursion uses AI to analyze images of cells and train artificial intelligence to understand the vast unknown biological space driving disease.
Mission & Story
Mission
Decoding biology to radically improve lives
Founding Story
Recursion was founded more than a decade ago on the idea that we could take images of cells and use these images to train artificial intelligence to understand the vast unknown biological space – the cellular disruptions driving disease – to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery.
Clinical Focus
Medical conditions and clinical areas addressed by Recursion Pharmaceuticals.
Who It Serves
Milestones & Awards
Recent Milestones
First patient dosed in Phase 1 clinical study of REC-3565 for B-cell lymphomas; Positive Phase 1b/2 results from REC-4881 TUPELO trial; Built BioHive-2 supercomputer with NVIDIA
Awards & Recognition
Founding member of BioHive (fastest growing life sciences community in the nation)
Key Partnerships
Recursion Pharmaceuticals in the News
All News →
Company Details
- Founded
- 2013
- Headquarters
- Salt Lake City, UT, USA
- Employees
- 1500
- Stage
- public
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.